Predicting ecstasy use among young people at risk: A prospective study of initially ecstasy-naive subjects

被引:7
|
作者
Vervaeke, Hylke K. E. [1 ]
Benschop, Annemieke [1 ]
van den Brink, Wim [1 ]
Korf, Dirk J. [1 ]
机构
[1] Univ Amsterdam, Bonger Inst Criminol, NL-1000 BA Amsterdam, Netherlands
关键词
D O I
10.2190/DE.38.2.c
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Our aim is to identify predictors of first-time ecstasy use in a prospective study among young people at risk. As part of the multidisciplinary Netherlands XTC Toxicity Study (NeXT), we monitored 188 Subjects aged >= 18 who were ecstasy-naive at baseline but seemed likely to start taking ecstasy in the near future. After an 11- to 26-month follow-up period, 160 respondents remained (85.1%; mean age 21.0 years, 58.1% females): 65 who took ecstasy at least once (ecstasy users) and 95 non-users. At baseline and four times during follow-up, respondents completed self-report questionnaires. Cox regression analysis was used to examine the effects of baseline respondent characteristics on incident ecstasy use. Development of peer group ecstasy use was analyzed by logistic regression. Intention to use ecstasy, low education, and current weekly cannabis use independently increased the hazard rate for first ecstasy use. Although ecstasy use among peers at baseline was not a predictor, the proportion of ecstasy users with ecstasy-using peers increased markedly during the study. Our results suggest that targeted prevention activities should focus in particular on young people who have strong intentions to take ecstasy, especially if they are also regular smokers of cannabis.
引用
收藏
页码:131 / 146
页数:16
相关论文
共 50 条
  • [1] MEDMA/ecstasy use among young people in Ohio: Perceived risk and barriers to intervention
    Carlson, RG
    Falck, RS
    McCaughan, JA
    Siegal, HA
    JOURNAL OF PSYCHOACTIVE DRUGS, 2004, 36 (02) : 181 - 189
  • [2] Psychosocial determinants of ecstasy use in young people in the UK
    Conner, M
    Sherlock, K
    BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 1998, 3 : 295 - 317
  • [3] Risk for Ecstasy Use Disorder and Other Substance Use Among International Users of Recreational Ecstasy/Molly/MDMA
    Haug, Nancy A.
    Wadekar, Richa
    Barry, Rachel
    Sottile, James
    JOURNAL OF PSYCHOACTIVE DRUGS, 2024, 56 (03) : 412 - 421
  • [4] Prevalence and Effective Factors on Ecstasy Use among Young Iranian
    Bagheri, Nahid
    Mirzaee, Moghaddameh
    Jahani, Yunes
    Sharifi, Hamid
    Bashiri, Yousef
    RafieiRad, Ali Ahmad
    Moghadam, Maryam Sargolzaie
    Dehghani-Arani, Monireh
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2018, 6 (03): : 280 - 286
  • [5] Alcohol use and risk taking among regular ecstasy users
    Breen, C
    Degenhardt, L
    Kinner, S
    Bruno, R
    Jenkinson, R
    Matthews, A
    Newman, J
    SUBSTANCE USE & MISUSE, 2006, 41 (08) : 1095 - 1109
  • [6] Decision making as a predictor of first ecstasy use: a prospective study
    Thelma Schilt
    Anneke E. Goudriaan
    Maarten W. Koeter
    Wim van den Brink
    Ben Schmand
    Psychopharmacology, 2009, 203 : 519 - 527
  • [7] Factors associated with condom use among young adult ecstasy users
    Elifson, Kirk W.
    Klein, Hugh
    Sterk, Claire E.
    INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2010, 55 (06) : 571 - 579
  • [8] Decision making as a predictor of first ecstasy use: a prospective study
    Schilt, Thelma
    Goudriaan, Anneke E.
    Koeter, Maarten W.
    van den Brink, Wim
    Schmand, Ben
    PSYCHOPHARMACOLOGY, 2009, 203 (03) : 519 - 527
  • [9] YOUNG ADULTS' TRAJECTORIES OF ECSTASY USE: A POPULATION BASED STUDY
    Smirnov, Andrew
    Najman, Jake M.
    Hayatbakhsh, Reza
    Plotnikova, Maria
    Wells, Helene
    Legosz, Margot
    Kemp, Robert
    DRUG AND ALCOHOL REVIEW, 2013, 32 : 64 - 64
  • [10] A Prospective Cohort Study on Sustained Effects of Low-Dose Ecstasy Use on the Brain in New Ecstasy Users
    Maartje M L de Win
    Liesbeth Reneman
    Gerry Jager
    Erik-Jan P Vlieger
    Sílvia D Olabarriaga
    Cristina Lavini
    Ivo Bisschops
    Charles B L M Majoie
    Jan Booij
    Gerard J den Heeten
    Wim van den Brink
    Neuropsychopharmacology, 2007, 32 : 458 - 470